Filing Date Form TypeDescription   
   
Data pager
12
 Page 1 of 2, items 1 to 13 of 14.
2019-11-068-KCurrent report, items 2.02 and 9.01 Acc-no: 0001213900-19-022198 (34 Act)  Size: 115 KB
2019-08-088-KCurrent report, items 2.02 and 9.01 Acc-no: 0001213900-19-014955 (34 Act)  Size: 116 KB
2019-06-078-KCurrent report, item 5.07 Acc-no: 0001213900-19-010341 (34 Act)  Size: 23 KB
2019-06-048-KCurrent report, items 1.01, 3.03, and 9.01 Acc-no: 0001615774-19-009097 (34 Act)  Size: 47 KB
2019-05-098-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-19-007378 (34 Act)  Size: 98 KB
2019-02-148-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-19-002524 (34 Act)  Size: 123 KB
2018-11-018-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-011870 (34 Act)  Size: 169 KB
2018-09-218-KCurrent report, items 8.01 and 9.01 Acc-no: 0001615774-18-009793 (34 Act)  Size: 40 KB
2018-09-178-KCurrent report, items 1.01 and 9.01 Acc-no: 0001615774-18-009597 (34 Act)  Size: 214 KB
2018-08-028-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-007460 (34 Act)  Size: 127 KB
2018-06-118-KCurrent report, item 5.07 Acc-no: 0001615774-18-005040 (34 Act)  Size: 17 KB
2018-05-038-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-003269 (34 Act)  Size: 98 KB
2018-02-018-KCurrent report, items 2.02 and 9.01 Acc-no: 0001615774-18-000772 (34 Act)  Size: 130 KB


Sensus Healthcare Reports Third Quarter 2019 Financial Results
11/6/2019 9:02:00 PM

Conference call begins at 4:30 p.m. Eastern time today


Sensus Healthcare to Host Third Quarter 2019 Financial Results and Business Update Conference Call on November 6, 2019
11/1/2019 1:57:00 PM

BOCA RATON, Fla., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the third quarter ended September 30, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare Reports Second Quarter 2019 Financial Results
8/8/2019 8:05:00 PM

BOCA RATON, Fla., Aug. 08, 2019 (GLOBE NEWSWIRE) --  Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions, announces financial results for the three and six months ended June 30, 2019.


Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019
7/30/2019 6:57:00 PM

BOCA RATON, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, August 8, 2019 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter ended June 30, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.


Sensus Healthcare to Present at the Raymond James Inaugural Life Sciences and MedTech Conference
6/10/2019 3:00:00 PM

BOCA RATON, Fla., June 10, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, CEO of the Company, will present a corporate overview at the Raymond James Inaugural Life Sciences and MedTech Conference on Wednesday, June 19 at 2:25 p.m. Eastern time.  The conference will be held June 18-19, 2019 at the Lotte New York Palace Hotel in New York City.


Sensus Healthcare to Present at Upcoming Investor Conferences
9/5/2017 2:50:00 PM

Management unable to present at Liolios Gateway conference due to Hurricane Irma
Management unable to present at Liolios Gateway conference due to Hurricane Irma

Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017
8/23/2017 8:01:00 PM

BOCA RATON, Fla., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel San Francisco.


Sensus to Present at the 2017 Marcum MicroCap Conference
6/5/2017 2:18:00 PM

BOCA RATON, Fla., June 05, 2017 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, June 15th at 11:00 a.m. Eastern time. The conference will be held at the Grand Hyatt Hotel in New York City on June 15th and 16th.


Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference
May 15, 2019, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

Sensus Healthcare Reports First Quarter 2019 Financial Results
May 09, 2019, 16:02 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

Sensus Healthcare to Present at the 31st Annual ROTH Conference
Mar 13, 2019, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

U.S. FDA Grants Market Clearance to Sensus Healthcare's New Sculptura™ Radiation Oncology System
Feb 26, 2019, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...

Sensus Healthcare to Host Fourth Quarter and Full Year 2018 Financial Results and Business Update Conference Call on February 14, 2019
Jan 30, 2019, 09:00 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Brings Groundbreaking SRT-100 Vision System to Israel's Largest Hospital for Skin Cancer and Keloid Treatment
Oct 17, 2018, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...

Sensus Healthcare, Inc. Announces Commencement of Public Offering of Common Stock
Sep 12, 2018, 16:19 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley...

Sensus Healthcare Presents at National Cancer Care Alliance Leadership Board and Practice Quarterly Meeting
Sep 07, 2018, 08:04 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Second Quarter Financial Results Feature Continued Strong Revenue Growth
Aug 02, 2018, 16:01 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare to Host Second Quarter 2018 Financial Results and Business Update Conference Call on August 2, 2018
Jul 24, 2018, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Announces Strategic Agreement with SkinCure Oncology
Jul 12, 2018, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...

Sensus Healthcare to Join Russell Microcap® Index
Jun 25, 2018, 08:00 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
Jun 12, 2018, 07:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth
May 03, 2018, 04:00 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Launches SRT-100 in China for Keloid Prevention and Treatment at Major Dermatology Conference, Extends Distribution Agreement with Chindex Medical
Nov 01, 2017, 07:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Announces Clearance to Market the SRT-100™ in Mexico
Oct 31, 2017, 07:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids
Jul 26, 2017, 07:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...

Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce
May 24, 2017, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare to Present at the 29th Annual ROTH Conference
Mar 07, 2017, 09:30 ET

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, ...

Sensus Healthcare to Announce Fourth Quarter and Full Year 2016 Results on February 2, 2017
Jan 19, 2017, 07:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare to Participate in Annual JP Morgan Healthcare Conference Week on January 9th - 11th in San Francisco
Jan 03, 2017, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare Receives the BioFlorida Company of the Year Award
Dec 13, 2016, 04:05 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare Reports Third Quarter 2016 Results
Nov 03, 2016, 04:05 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award
Sep 07, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin...

Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors
Aug 02, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences
Jul 25, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare, Inc. Announces Separation of Units Sold in IPO
Jul 21, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...

Sensus Healthcare to Announce Second Quarter 2016 Results on August 4, 2016
Jul 20, 2016, 08:30 ET

Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin...